Purchase Order 75N91024P00462
Award Date 8/7/24
Potential Completion Date 9/6/24
Potential Value $282K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $202,000.00 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for the provision of an Illumina NextSeq 500 sequencing system. The contract has no set-aside designation. Through past contract awards, Illumina has provided a range of genomic sequencing instruments, reagents, and support services to various federal agencies including the NIH, Centers for Disease Control and...
- This is a $114,198.14 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for their NextSeq 550 comprehensive service plan. The contract is not set aside and has an ultimate completion date of July 31, 2024. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal contracts and subcontracts from agencies...
- This is a $28,749.60 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Through this award, Illumina will provide the NCI with a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits,...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and consumables. The contract is for Illumina's NextSeq 500 Sequencing System Production Care comprehensive support plan, with a potential value of $145,851.23 and a completion date of January 31, 2023. Illumina has previously received awards from federal agencies like the...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract, valued at $81,640.80, is for the provision of NEXTSEQ 500/500 sequencing systems and related catalog items. The award has no set-aside designation. Illumina has previously provided sequencing systems and services to support...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genomics sequencing systems and reagents, for the procurement of an Illumina NextSeq 550 sequencing system. The $266,475 award was made on May 24, 2019 with an August 22, 2019 completion date. This purchase will complement the NCI's existing Illumina NextSeq 500 and MiSeq instruments used by...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $13,438.88 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support services, and bioinformatics products to support genomic research and diagnostics projects at the...
- This federal contract award is for the purchase of (QTY 2) Illumina NextSeq 550Dx sequencers by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI). The total potential value of the firm fixed price purchase order is $630,846.00. The contract was awarded to the prime vendor Illumina, Inc., a manufacturer of genomic sequencing and analysis products. The sequencing systems are intended to support the NCI's clinical next-generation...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the procurement of an Illumina NextSeq 2000 sequencing system with a trade-in. The total ceiling value of the award is $207,415.25 and the ultimate completion date is October 4, 2024. The contract does not have any set-aside designation. Based on Illumina's background as a manufacturer of genetic and genomic analysis instruments and reagents, this award is likely...